After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
TMO belongs to the Healthcare sector of the NYSE while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $551.75 and fluctuated between $553.28 as its day high and $541.84 as its day low. The current market capitalization of Thermo Fisher Scientific Inc. is $213.18B. A total of 2.12 million shares were traded on the day, compared to an average of 1.98M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, TMO has seen 3 BUY and 16 SELL insider trades, representing the acquisition of 21,600 and the disposition of 20,836 shares. Over the last 12 months, there were 44 BUYs and 176 SELLs from insiders. Insiders purchased 205,516 shares during that period but sold 208,516.
In the most recent transaction, CASPER MARC N sold 1,600 shares of TMO for 460.25 per share on Nov 07. After the transaction, the Chairman & CEO now owns 131,175 company shares. In a previous transaction on Nov 06, CASPER MARC N sold 10,000 shares at 454.41 per share. TMO shares that Chairman & CEO owns now total 131,175.
Among the insiders who sold shares, CASPER MARC N disposed of 10,000 shares on Nov 03 at a per-share price of $456.15. This resulted in the Chairman & CEO holding 131,175 shares of TMO after the transaction. In another insider transaction, CASPER MARC N sold 10,000 shares at $445.49 per share on Nov 02. Company shares held by the Chairman & CEO now total 131,175.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Thermo Fisher Scientific Inc. pays an annual dividend of $1.36, resulting in a dividend yield of 0.25%, and it has a price to earnings (P/E) ratio of 36.16. TMO’s most recent ex-dividend date was 12/14/2023 when it declared a $0.35 quarterly dividend that was paid in cash on 1/16/2024. Previously, the company paid the dividend on 10/13/2023 with an ex-dividend date of 9/14/2023. The TMO stock dividend was $0.35 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for TMO in the last 3 months, the mean price target is $549.23 with high estimates of $640.00 and low estimates of $435.00. In terms of 52-week highs and lows, TMO has a high of $609.85 and a low of $415.60.
As of this writing, TMO has an earnings estimate of $5.64 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of $5.73 per share and a lower estimate of $5.62. The company reported an EPS of $5.15 in the last quarter, which was -5.00% lower than expectations of $5.42.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TMO’s latest balance sheet shows that the firm has $4.48B in Cash & Short Term Investments as of fiscal 2021. There were $34.87B in debt and $13.44B in liabilities at the time. Its Book Value Per Share was $117.32, while its Total Shareholder’s Equity was $40.98B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Buy with a score of 4.42.
